Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Endocrinology

• Publication date

  2016-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.2015-2003PMID 27035653
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells

  2015cited by this paper
• Erratum to: The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells

  2015cited by this paper
• Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.

  2014cited by this paper
• Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic

  2014cited by this paper
• Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway

  2013cited by this paper
• GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice.

  2013cited by this paper
• Effect of the AMP-Kinase Modulators AICAR, Metformin and Compound C on Insulin Secretion of INS-1E Rat Insulinoma Cells under Standard Cell Culture Conditions

  2012cited by this paper
• Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

  2012cited by this paper
• Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes

  2012cited by this paper
• Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice

  2011cited by this paper
• Development and Functional Characterization of Insulin-releasing Human Pancreatic Beta Cell Lines Produced by Electrofusion*

  2011cited by this paper
• Obesity may attenuate the HbA1c‐lowering effect of sitagliptin in Japanese type 2 diabetic patients

  2011cited by this paper
• Suppression of the Pancreatic Duodenal Homeodomain Transcription Factor-1 (Pdx-1) Promoter by Sterol Regulatory Element-binding Protein-1c (SREBP-1c)*

  2011cited by this paper
• Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

  2010cited by this paper
• Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.

  2010cited by this paper
• SREBP‐1c, Pdx‐1, and GLP‐1R involved in palmitate–EPA regulated glucose‐stimulated insulin secretion in INS‐1 cells

  2010cited by this paper
• Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes.

  2010cited by this paper
• Sterol regulatory element‐binding protein‐1c knockdown protected INS‐1E cells from lipotoxicity

  2010cited by this paper
• A protocol for islet isolation from mouse pancreas

  2009cited by this paper
• Glucose, Metformin, and AICAR Regulate the Expression of G Protein-coupled Receptor Members in INS-1 β Cell

  2009cited by this paper
• Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients

  2008cited by this paper
• Palmitate Impairs and Eicosapentaenoate Restores Insulin Secretion Through Regulation of SREBP-1c in Pancreatic Islets

  2008cited by this paper
• Peroxisome proliferator-activated receptor-alpha regulates the expression of pancreatic/duodenal homeobox-1 in rat insulinoma (INS-1) cells and ameliorates glucose-induced insulin secretion impaired by palmitate.

  2008cited by this paper
• Sterol regulatory element-binding protein-1c and pancreatic beta-cell dysfunction.

  2007cited by this paper
• Sterol regulatory element–binding protein‐1c and pancreatic β‐cell dysfunction

  2007cited by this paper
• Downregulation of GLP-1 and GIP Receptor Expression by Hyperglycemia

  2007cited by this paper
• GLP-1: a new approach for type 2 diabetes therapy

  2006cited by this paper
• Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes

  2006cited by this paper
• Effects of rosiglitazone and metformin on pancreatic beta cell gene expression

  2006cited by this paper
• Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines.

  2005cited by this paper
• Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells

  2005cited by this paper
• Transgenic Mice Overexpressing Nuclear SREBP-1c in Pancreatic β-Cells

  2005cited by this paper
• Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP.

  2005cited by this paper
• Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1 Coactivation of SREBP

  2005cited by this paper
• Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta-cells.

  2005cited by this paper
• Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR).

  2004cited by this paper
• The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.

  2003cited by this paper
• The Transcription Factor SREBP-1c Is Instrumental in the Development of β-Cell Dysfunction*

  2003cited by this paper
• Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity.

  2002cited by this paper
• Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion*

  2002cited by this paper
• Minireview: Secondary β-Cell Failure in Type 2 Diabetes-A Convergence of Glucotoxicity and Lipotoxicity.

  2002cited by this paper
• Pdx1 Level Defines Pancreatic Gene Expression Pattern and Cell Lineage Differentiation*

  2001cited by this paper
• The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.

  2001cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function.

  2001cited by this paper
• Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets.

  2000cited by this paper
• Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells.

  2000cited by this paper
• Sterol Regulatory Element-binding Protein-1 as a Key Transcription Factor for Nutritional Induction of Lipogenic Enzyme Genes*

  1999cited by this paper
• Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice.

  1998cited by this paper
• The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

  1997cited by this paper
• A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM

  1995cited by this paper
• Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.

  1994cited by this paper
• Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

  1993cited by this paper
• Incretin Effect Due to Increased Secretion and Decreased Clearance of Insulin in Normal Humans

  1988cited by this paper
• Stimulation of insulin secretion by long-chain free fatty acids. A direct pancreatic effect.

  1973cited by this paper

• Association between CRP-TyG index and hepatic synthetic function in post-myocardial infarction ICU patients

  2025cites this paper
• Metformin restores prohormone processing enzymes and normalizes aberrations in secretion of proinsulin and insulin in palmitate‐exposed human islets

  2023cites this paper
• Pharmacological modulation of adaptive thermogenesis: new clues for obesity management?

  2023cites this paper
• Adipose Tissue Secretion Pattern Influences β-Cell Wellness in the Transition from Obesity to Type 2 Diabetes

  2022cites this paper
• Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity

  2021cites this paper
• IRS-2/Akt/GSK-3β/Nrf2 Pathway Contributes to the Protective Effects of Chikusetsu Saponin IVa against Lipotoxicity

  2021cites this paper
• Effects of Obesogenic Feeding and Free Fatty Acids on Circadian Secretion of Metabolic Hormones: Implications for the Development of Type 2 Diabetes

  2021cites this paper
• Exendin-4 gene modification and microscaffold encapsulation promote self-persistence and antidiabetic activity of MSCs

  2021cites this paper
• Non-coding RNAS Related to Type 2 Diabetes

  2021cites this paper
• Functional loss of pancreatic islets in type 2 diabetes: how can we halt it?

  2020cites this paper
• Modulation of Fatty Acid-Related Genes in the Response of H9c2 Cardiac Cells to Palmitate and n-3 Polyunsaturated Fatty Acids

  2020cites this paper
• Exendin‑4 inhibits lipotoxicity‑induced oxidative stress in β‑cells by inhibiting the activation of TLR4/NF‑κB signaling pathway.

  2020cites this paper
• Combined transcriptome and proteome profiling of the pancreatic β-cell response to palmitate unveils key pathways of β-cell lipotoxicity

  2020cites this paper
• Characterization of the Molecular Mechanisms Underlying Glucose Stimulated Insulin Secretion from Isolated Pancreatic (cid:2) -cells Using Post-translational Modification Specific Proteomics (PTMomics)*

  2020cites this paper
• The Mitochondria-Targeted Antioxidant MitoQ Modulates Mitochondrial Function and Endoplasmic Reticulum Stress in Pancreatic β Cells Exposed to Hyperglycaemia.

  2019cites this paper
• Contribution of Oxidative Stress and Impaired Biogenesis of Pancreatic β-Cells to Type 2 Diabetes

  2019cites this paper
• Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity

  2018cites this paper
• Cellular models for beta‐cell function and diabetes gene therapy

  2018cites this paper
• Palmitate-Induced SREBP1 Expression and Activation Underlies the Increased BACE 1 Activity and Amyloid Beta Genesis

  2018cites this paper
• Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy

  2018cites this paper
• Palmitate-induced lipotoxicity alters acetylation of multiple proteins in clonal β cells and human pancreatic islets

  2017cites this paper
• Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats

  2017cites this paper
• Abnormal CFTR Affects Glucagon Production by Islet α Cells in Cystic Fibrosis and Polycystic Ovarian Syndrome

  2017cites this paper
• Glucotoxicity promotes aberrant activation and mislocalization of Ras-related C3 botulinum toxin substrate 1 [Rac1] and metabolic dysfunction in pancreatic islet β-cells: reversal of such metabolic defects by metformin

  2017cites this paper
• Metformin, Glucotoxicity And Islet Dysfunction

  2017cites this paper
• Characterization of the Molecular Mechanisms Underlying Glucose Stimulated Insulin Secretion from Isolated Pancreatic β-cells Using Post-translational Modification Specific Proteomics (PTMomics)*

  2017cites this paper
• Characterization of the Molecular Mechanisms Underlying Glucose Stimulated Insulin Secretion from Isolated Pancreatic β-cells Using Post-translational Modification Specific Proteomics (PTMomics)

  2017cites this paper
• Islet hormonal hypersecretion and metformin’s effect on islet hormonal secretion studied in vitro and in vivo

  year unknowncites this paper